DANIEL EMINA: Open Payments
NPI 1861633786 · COSTA MESA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 26 payments from 8 companies in 2025. Trend: 2023 $469 · 2024 $1,161 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $168 |
| Axsome Therapeutics, Inc. | 5 | $134 |
| ABBVIE INC. | 4 | $82 |
| Lundbeck LLC | 3 | $77 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
| Corium, LLC | 2 | $34 |
| Lilly USA, LLC | 1 | $23 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, Sunosi, COBENFY, Azstarys, ZEPBOUND.
Industry payments across CA — which companies pay providers there.
